Home
The Department of Biomedicine

News archive for The Department of Biomedicine

Henriette Christie Ertsås defends her dissertation “The effects of ageing on microenvironment-contextual epithelialcell signalling” at the University of Bergen
These researchers have made a sensational finding in cell biology. Adrian Drazic, Henriette Aksnes and Michaël Marie from Thomas Arnesen's group found an enzyme that others have been looking for for 30 years.
The Proteomics Unit of the University of Bergen, PROBE, and the Norwegian Proteomics Society organize this edition of the Nordic Proteomics Conference NPC 2018
Open for registration, deadline 23rd of February.
At the UiB, health minister Bent Høie met representatives of the health industry and health institutions to receive input for a new parliamentary report on the health industry.
Compared with adult men with ADHD, adult ADHD women have an increased risk of experiencing anxiety and depression, shows a new UiB study. Men with ADHD in contrast suffer more from substance abuse and schizophrenia.
People who are diagnosed with ADHD report more sleep problems – 15 times more so for certain types of sleep disorders than others without the diagnosis. “These are surprisingly large differences”, says the UiB-researcher behind the study.
Consolidator Grants from the European Research Council for excellent research projects.
Ruth Brenk at The Department of biomedicine received a grant of 7 million NOK for research to discover new antibiotics. The work will be carried out with collaborators at the Indian Institute of Chemical Technology.
Thomas Arnesen is one of five Norwegian researchers who will receive a prestigious consolidator grant from the European Research Council in 2017.
Researchers at the Department of Biomedicine participate in an international research project that has now found a promising compound which could turn into an effective drug against malaria.
Bortezomib as chemosensitizer for glioblastoma patients with unmethylated MGMT promoter: Phase IB/II clinical trial and mechanisms of therapeutic efficacy
Doctoral candidates from around the world have gathered to communicate their research on the retina. The result is an interactive eye exhibit at VilVite Science Center.
A new study performed at UiB shows that the blood-thinning drug warfarin may prevent the development of cancer
Gry Sandvik Haaland defends her dissertation “Investigations of the cancer therapeutic and protective effects of warfarin mediated inhibition of the receptor tyrosine kinase AXL”

Pages